Bio Protocol vs Sui — how do they compare? Bio Protocol trades at Rp440.32 (market cap Rp1T, Rp164,61M 24h volume), while Sui trades at Rp12,214 (market cap Rp49,72T, Rp2,11T 24h volume). The key difference: Sui is far larger — about 49.7× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 4,1B / 10B SUI (41%) for Sui. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Sui for 37 Days on average.
| BIO | SUI | |
|---|---|---|
Market Cap | Rp1T | Rp49,72T |
Volume (24h) | Rp164,61M | Rp2,11T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 4,1B / 10B SUI (41%) |
Typical Hold Time | 18 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Sui is currently trading at Rp12,306 with a market cap of Rp50.06T, showing a bearish technical signal overall. The asset has 41% circulating supply with a 37-day average hold time. Technical indicators show mixed signals with moving averages bearish but oscillators neutral. Recent ecosystem developments include strategic partnerships expanding token utility and lending activities on the Sui blockchain.
Overall outlook remains cautious with bearish technical pressure but neutral momentum. Key opportunities include growing ecosystem partnerships and expanding DeFi integration. Major risks include high volatility, regulatory uncertainty, and the asset trading near pivot point resistance levels.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Sui is a first-of-its-kind Layer-1 blockchain and smart contract platform designed from the bottom up to make digital asset ownership fast, private, secure, and accessible to everyone. Based on the Move programming language, its object-centric model enables parallel execution, sub-second finality, and rich on-chain assets. Sui supports a wide range of applications with unrivaled speed at a low cost.
Read more on SUI →